Extracellular vesicles in coronary artery disease, Nat 3 Rev Cardiol, vol.14, pp.259-72, 2017. ,
Membrane vesicles, current state-of-the-art: emerging 5 role of extracellular vesicles, Cell Mol Life Sci CMLS, vol.68, pp.2667-88, 2011. ,
Focus on Extracellular Vesicles: New Frontiers of Cell-7 to-Cell Communication in Cancer, Int J Mol Sci, vol.17, p.175, 2016. ,
The many faces of endothelial microparticles, Arterioscler 9 Thromb Vasc Biol, vol.31, pp.27-33, 2011. ,
Microvesicles in vascular homeostasis 11 and diseases, Thromb Haemost, vol.117, pp.1296-316, 2017. ,
Thrombosis as an intravascular effector of innate immunity, Nat 13 Rev Immunol, vol.13, pp.34-45, 2013. ,
Calcium-dependent phospholipid scrambling by TMEM16F. 15, Nature, vol.468, pp.834-842, 2010. ,
Platelet membrane phospholipid asymmetry: from the 17 characterization of a scramblase activity to the identification of an essential protein mutated 18 in Scott syndrome, J Thromb Haemost JTH, vol.9, pp.1883-91, 2011. ,
Tumor shedding and coagulation, Science, vol.212, pp.20-923, 1981. ,
Procoagulant activity associated with plasma 22 membrane vesicles shed by cultured tumor cells, Cancer Res, vol.43, pp.4434-4476, 1983. ,
Regulation of the incorporation of tissue factor into microparticles by 24 serine phosphorylation of the cytoplasmic domain of tissue factor, J Biol Chem, vol.286, pp.25-11977, 2011. ,
Filamin-A is required for the incorporation of tissue 27 factor into cell-derived microvesicles, Thromb Haemost, vol.111, p.15, 2014. ,
Oligoubiquitination of tissue factor on Lys255 31 promotes Ser253-dephosphorylation and terminates TF release, Biochim Biophys Acta, vol.32, pp.2846-57, 2016. ,
Tissue Factor Prothrombotic Activity Is Regulated 34 by Integrin-arf6 Trafficking, Arterioscler Thromb Vasc Biol, vol.37, pp.1323-1354, 2017. ,
Interaction of endothelial microparticles with monocytic 36 cells in vitro induces tissue factor-dependent procoagulant activity, Blood, vol.99, p.33, 2002. ,
Breast-cancer extracellular vesicles induce platelet 1 activation and aggregation by tissue factor-independent and -dependent mechanisms ,
, Thromb Res, vol.159, pp.24-32, 2017.
Accumulation of tissue factor into developing thrombi in vivo is 4 dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin, J Exp 5 Med, vol.197, pp.1585-98, 2003. ,
Hematopoietic cell-derived microparticle tissue 7 factor contributes to fibrin formation during thrombus propagation, Blood, vol.104, pp.3190-3197, 2004. ,
Microparticles in hemostasis and thrombosis, Circ Res, vol.108, pp.9-1284, 2011. ,
Tissue factor-bearing microparticles and thrombus 11 formation, Arterioscler Thromb Vasc Biol, vol.31, pp.728-761, 2011. ,
Mechanistic view of risk factors for venous 13 thromboembolism, Arterioscler Thromb Vasc Biol, vol.32, pp.563-571, 2012. ,
Fibrin-bearing microparticles: marker of thrombo-15 embolic events in pancreatic and colorectal cancers, Oncotarget, vol.8, p.40, 2017. ,
Mouse models of cancer-associated thrombosis, Thromb Res, vol.164, pp.48-53, 2018. ,
Prognosis of cancers associated with venous 19 thromboembolism, N Engl J Med, vol.343, pp.1846-50, 2000. ,
Microparticle-associated tissue factor 21 activity: a link between cancer and thrombosis?, J Thromb Haemost, vol.5, pp.520-527, 2007. ,
Tumor-derived tissue factor-bearing microparticles 23 are associated with venous thromboembolic events in malignancy, Clin Cancer Res Off J Am 24 Assoc Cancer Res, vol.15, pp.6830-6870, 2009. ,
Increased microparticle tissue factor activity in cancer 26 patients with Venous Thromboembolism, Thromb Res, vol.125, pp.511-513, 2010. ,
Endothelial, platelet, and tissue factor-bearing 28 microparticles in cancer patients with and without venous thromboembolism, Thromb Res, vol.29, pp.473-480, 2011. ,
Coagulation activation and microparticle-33 associated coagulant activity in cancer patients. An exploratory prospective study, Thromb 34 Haemost, vol.6, pp.160-165, 2008. ,
Circulating microparticles of glial origin and tissue 36 factor bearing in high-grade glioma: a potential prothrombotic role, Thromb Haemost, vol.37, pp.378-85, 2013. ,
Circulating microparticle tissue factor, 1 thromboembolism and survival in pancreaticobiliary cancers, Thromb Res, vol.132, p.50, 2013. ,
Tissue factor-bearing microparticles 3 and CA19.9: two players in pancreatic cancer-associated thrombosis?, Br J Cancer, vol.115, pp.4-332, 2016. ,
Extracellular vesicles exposing tissue factor for the 6 prediction of venous thromboembolism in patients with cancer: A prospective cohort study ,
, Thromb Res, vol.166, pp.54-63, 2018.
Biomarkers for the risk of thrombosis in 9 pancreatic adenocarcinoma are related to cancer process, Oncotarget, vol.9, p.53, 2018. ,
Circulating procoagulant microparticles in cancer patients ,
URL : https://hal.archives-ouvertes.fr/hal-00589430
, Ann Hematol, vol.90, pp.447-53, 2011.
Microparticle-associated tissue factor activity, venous 13 thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients, J 14 Thromb Haemost, vol.10, pp.1363-70, 2012. ,
Tissue factor expressed by microparticles is associated 16 with mortality but not with thrombosis in cancer patients, Thromb Haemost, vol.110, p.598, 2013. ,
Tissue Factor-bearing MPs and the risk of venous thrombosis 19 in cancer patients: A meta-analysis, Sci Rep, vol.8, p.57, 2018. ,
Cancer-associated pathways and biomarkers of venous thrombosis, Blood, vol.130, pp.1499-506, 2017. ,
Microparticles and cancer thrombosis in animal 23 models, Thromb Res, vol.140, pp.21-27, 2016. ,
Cancer cell-derived microparticles bearing P-25 selectin glycoprotein ligand 1 accelerate thrombus formation in vivo, J Exp Med, vol.206, pp.26-1913, 2009. ,
Inhibition of platelet activation prevents the 28 P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces 29 tumor growth and metastasis in vivo, Int J Cancer, vol.136, pp.462-75, 2015. ,
Tissue factor expressed by circulating cancer cell-derived 31 microparticles drastically increases the incidence of deep vein thrombosis in mice, J Thromb 32 Haemost, vol.13, pp.1310-1319, 2015. ,
Tissue factor-positive tumor microvesicles activate 34 platelets and enhance thrombosis in mice, J Thromb Haemost, vol.14, pp.153-66, 2016. ,
Human pancreatic tumors grown in mice release tissue 36 factor-positive microvesicles that increase venous clot size, J Thromb Haemost, vol.15, pp.37-2208, 2017. ,
Tissue factor-bearing microparticles and inflammation: a 1 potential mechanism for the development of venous thromboembolism in cancer, J Thromb 2 Haemost JTH, vol.15, pp.2289-99, 2017. ,
Distinct Pathogenesis of Pancreatic Cancer Microvesicle-4 ,
, Associated Venous Thrombosis Identifies New Antithrombotic Targets In Vivo, Arterioscler 5 Thromb Vasc Biol, vol.38, pp.772-86, 2018.
Low-molecular-weight heparin versus a coumarin for the 7 prevention of recurrent venous thromboembolism in patients with cancer, N Engl J Med, vol.8, pp.146-53, 2003. ,
Tinzaparin vs Warfarin for Treatment of Acute 10 ,
, Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial, JAMA, vol.11, pp.677-86, 2015.
The polyphosphate/factor XII pathway in cancer-18 associated thrombosis: novel perspectives for safe anticoagulation in patients with 19 malignancies, Am J Hematol, vol.93, issue.2, pp.4-7, 2015. ,
Involvement of the snake toxin receptor CLEC-2, in 21 podoplanin-mediated platelet activation, by cancer cells, J Biol Chem, vol.282, p.72, 2007. ,
Microparticle-associated tissue factor activity in patients 23 with metastatic pancreatic cancer and its effect on fibrin clot formation, Transl Res J Lab Clin 24 Med, vol.163, pp.145-50, 2014. ,
Podoplanin expression in primary brain tumors induces 26 platelet aggregation and increases risk of venous thromboembolism, Blood, vol.129, p.1831, 2017. ,
Tumor-Derived Exosomes Induce the Formation of 29 ,
, Neutrophil Extracellular Traps: Implications For The Establishment of Cancer-Associated 30 Thrombosis, Sci Rep, vol.7, p.6438, 2017.
Comparison of anticoagulant and procoagulant 32 activities of stimulated platelets and platelet-derived microparticles, Blood, vol.77, p.76, 1991. ,
Binding of anticoagulant vitamin K-dependent protein S to 34 platelet-derived microparticles, Biochemistry, vol.31, pp.12769-77, 1992. ,
Platelet protein S directly inhibits procoagulant activity 36 on platelets and microparticles, Thromb Haemost, vol.109, p.78, 2013. ,
Activated protein C induces the release of 38 microparticle-associated endothelial protein C receptor, Blood, vol.105, p.79, 2005. ,
The significance of human monocyte thrombomodulin during 1 membrane vesiculation and after stimulation by lipopolysaccharide, Br J Haematol, vol.96, pp.2-534, 1997. ,
Tissue factor pathway inhibitor on circulating 4 microparticles in acute myocardial infarction, Thromb Haemost, vol.93, pp.35-44, 2005. ,
Involvement of microparticles in diabetic vascular 6 complications, Thromb Haemost, vol.106, pp.310-331, 2011. ,
Monocyte-derived microparticles and exosomes induce 8 procoagulant and apoptotic effects on endothelial cells, Thromb Haemost, vol.100, pp.878-85, 2008. ,
Microparticles bearing tissue factor and tissue factor 10 pathway inhibitor in gestational vascular complications, J Thromb Haemost, vol.7, p.84, 2009. ,
Chemotherapy administration to breast cancer 12 patients affects extracellular vesicles thrombogenicity and function, Oncotarget, vol.8, pp.13-63265, 2017. ,
Inhibition of tissue factor pathway inhibitor increases 15 the sensitivity of thrombin generation assay to procoagulant microvesicles, Blood Coagul, p.16 ,
, Fibrinolysis Int J Haemost Thromb, vol.24, pp.567-72, 2013.
The effect of corn trypsin inhibitor, anti-tissue factor 18 pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin 19 generation in patients with pancreatic cancer and healthy controls, PloS One, vol.12, p.87, 2017. ,
Human breast carcinoma cells cultured in the presence of 22 serum shed membrane vesicles rich in gelatinolytic activities, J Submicrosc Cytol Pathol, vol.23, pp.173-80, 1994. ,
Urokinase plasminogen activator and gelatinases are 25 associated with membrane vesicles shed by human HT1080 fibrosarcoma cells, J Biol Chem, vol.26, pp.17216-17238, 1997. ,
Selective localization of matrix metalloproteinase 9, beta1 28 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 29 8701-BC breast carcinoma cells, Cancer Res, vol.58, pp.4468-74, 1998. ,
Matrix-degrading proteinases are shed in membrane 31 vesicles by ovarian cancer cells in vivo and in vitro, Clin Exp Metastasis, vol.17, p.91, 1999. ,
Membrane vesicles in ovarian cancer fluids: a new potential 33 marker, Anticancer Res, vol.19, pp.3439-3484, 1999. ,
Proinvasive properties of ovarian cancer ascites-derived 35 membrane vesicles, Cancer Res, vol.64, pp.7045-7054, 2004. ,
Osteoblast-conditioned media stimulate 37 membrane vesicle shedding in prostate cancer cells, Int J Oncol, vol.28, p.94, 2006. ,
The amount and proteolytic content of vesicles shed 1 by human cancer cell lines correlates with their in vitro invasiveness, Anticancer Res, vol.18, issue.2, pp.3433-3440, 1998. ,
Vesicle-associated urokinase plasminogen 4 activator promotes invasion in prostate cancer cell lines, Clin Exp Metastasis, vol.18, pp.163-168, 2000. ,
CD44v6 dependence of premetastatic niche preparation 7 by exosomes, Neoplasia N Y N, vol.11, pp.1093-105, 2009. ,
Secretion of extracellular hsp90alpha via exosomes 9 increases cancer cell motility: a role for plasminogen activation, BMC Cancer, vol.10, p.98, 2010. ,
Activation of plasminogen into plasmin at the surface of 11 endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial 12 progenitor cells in vitro, Blood, vol.110, pp.2432-2441, 2007. ,
Fibrinolytic cross-talk: a new mechanism for 14 plasmin formation, Blood, vol.115, pp.2048-56, 2010. ,
Leukocyte-and endothelial-derived microparticles: a 16 circulating source for fibrinolysis, Haematologica, vol.97, pp.1864-72, 2012. ,
Microparticles: new protagonists in pericellular and intravascular 18 proteolysis, Semin Thromb Hemost, vol.39, pp.33-42, 2013. ,
Role of microparticles in the hemostatic dysfunction in acute 20 promyelocytic leukemia, Semin Thromb Hemost, vol.36, pp.917-941, 2010. ,
Analysis of the thrombotic and fibrinolytic activities of 22 tumor cell-derived extracellular vesicles, Blood Adv, vol.2, pp.1054-65, 2018. ,
Mast cell-derived exosomes activate endothelial cells 24 to secrete plasminogen activator inhibitor type 1, Arterioscler Thromb Vasc Biol, vol.25, pp.25-1744, 2005. ,
Thrombotic characteristics of extracellular 27 vesicles derived from prostate cancer cells, The Prostate, vol.78, pp.953-61, 2018. ,
Revisited role of microparticles in arterial and venous 29 thrombosis, J Thromb Haemost JTH, vol.11, issue.1, pp.24-35, 2013. ,
Microparticles and Fibrinolysis, Semin Thromb Hemost, vol.31, pp.129-163, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01460632
A new assay to evaluate microvesicle plasmin 33 generation capacity: validation in disease with fibrinolysis imbalance, J Extracell Vesicles, vol.34, p.1494482, 2018. ,
Impact of pre-analytical parameters on the 36 measurement of circulating microparticles: towards standardization of protocol, J Thromb 37 Haemost JTH, vol.10, pp.437-483, 2012. ,
Methodological Guidelines to Study Extracellular 1 Vesicles, Circ Res, vol.120, pp.1632-1680, 2017. ,
Optical and surface plasmonic approaches to characterize 3 extracellular vesicles. A review, Anal Chim Acta, vol.1005, pp.1-15, 2018. ,
Update on functional and genetic laboratory assays for 5 the detection of platelet microvesicles, Platelets, vol.28, pp.235-276, 2017. ,
Tips and tricks for flow cytometry-based analysis and 7 counting of microparticles, Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc 8 Haemapheresis, vol.53, pp.110-136, 2015. ,
Detection of platelet vesicles by flow cytometry, Platelets, vol.28, pp.256-266, 2017. ,
Detection of tissue factor-positive extracellular 12 vesicles by laser scanning confocal microscopy, Thromb Res, vol.150, pp.65-72, 2017. ,
A new activated factor X-based clotting method with improved 14 specificity for procoagulant phospholipid, Blood Coagul Fibrinolysis Int J Haemost Thromb, vol.15, pp.773-782, 2003. ,
Measuring circulating cell-derived microparticles, J 17 Thromb Haemost JTH, vol.2, pp.1842-51, 2004. ,
The calibrated automated thrombogram (CAT): a 19 universal routine test for hyper-and hypocoagulability, Pathophysiol Haemost Thromb, vol.20, pp.249-53, 2002. ,
Microparticle-associated tissue factor activity 22 measured with the Zymuphen MP-TF kit and the calibrated automated thrombogram assay ,
, Blood Coagul Fibrinolysis Int J Haemost Thromb, vol.23, pp.520-526, 2012.
Measurement of microparticle tissue factor activity in 25 clinical samples: A summary of two tissue factor-dependent FXa generation assays, Thromb 26 Res, vol.139, pp.90-97, 2016. ,
Evaluation of a new commercial assay to measure 28 microparticle tissue factor activity in plasma: communication from the SSC of the ISTH, J 29 Thromb Haemost, vol.12, pp.1932-1936, 2014. ,
New specific and highly sensitive procoagulant test to 31 measure tissue factor activity on microparticles, Res Pr Thromb Haemost Berlin, vol.1, p.1087, 2017. ,
Measurement of tissue factor activity in extracellular vesicles from 33 human plasma samples. Res Pr Thromb Haemost, 2018. ,
Human cell-derived microparticles promote 36 thrombus formation in vivo in a tissue factor-dependent manner, J Thromb Haemost, vol.1, pp.37-2561, 2003. ,
Cell-derived vesicles exposing coagulant tissue 1 factor in saliva, Blood, vol.117, pp.3172-80, 2011. ,